To assess the antagonistic effect of CAPE on TGFβ treatments in bladder carcinoma cells, we treated HT1376 cells with CAPE and/or rhTGFβ to determine the expressions of GDF15, maspin, and NDRG1. The gene discussed is SERPINB5; the disease is urinary bladder carcinoma.